Recent News

By Category: Countermeasures

Ricin Vaccine Effective Against Aerosolized Toxin

(Global Biodefense) Soligenix, Inc. today announced promising preliminary results from a preclinical study with its ricin toxin vaccine RiVax, in a non-human primate (NHP) lethal aerosol exposure model. The study demonstrated that NHPs vaccinated with RiVax were completely protected against a lethal aerosol of ricin toxin with a highly significant survival benefit

Protecting produce: ten African countries get biosecurity investment

(The Guardian) The Australian International Food Security Research Centre recently announced the launch of a two-year, $800,000 initiative for sub-Saharan Africa. The project aims to help 10 countries become better equipped to combat plant biosecurity threats.

White House orders biosafety review at federal labs

(Science/AAAS) The White House is asking federally funded labs studying infectious agents to take “immediate action” to inventory samples and review safety and security procedures in the wake of several high-profile accidents earlier this year.

NIH to Launch Human Safety Study of Ebola Vaccine Candidate

(NIH News)-​Initial human testing of an investigational vaccine to prevent Ebola virus disease will begin next week by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

Expanding age of eligibility for measles vaccination could increase childhood survival in Africa

(Science Daily) Expanding the age of eligibility for measles vaccination from 12 to 15 months could have potentially large effects on coverage in Africa, according to a new report. If combined with improvements to the vaccination process itself, such a change could help the country inch closer to the national coverage levels required for measles eradication

« First...1112131415...203040...Last »

Also filed under "Countermeasures":